ATAI Life Sciences NV (9VC) — Cash Flow Quality Index

Latest as of September 2023: -0.42x

ATAI Life Sciences NV (9VC) has a Cash Flow Quality Index of -0.42x as of September 2023. Operating cash flow of €-18.43 Million is below net income of €44.24 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ATAI Life Sciences NV (9VC) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.42x

Operating CF / Net Income

Operating Cash Flow

€-18.43 Million

EUR

Net Income

€44.24 Million

EUR

Data as of

Sep 2023

Most recent filing

Annual Cash Flow Quality Index for ATAI Life Sciences NV (None–None)

Year-by-year earnings quality comparison for ATAI Life Sciences NV.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.